VYNE Therapeutics

-$0.17 (-4.46%) Today
+$0.01 (+0.27%) As of 9:07 PM UTC after-hours

Why Robinhood?

You can buy or sell VYNE and other stocks, options, and ETFs commission-free!

About VYNE

VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercialize solutions using its proprietary Molecule Stabilizing Technology.

CEO
David Domzalski
Employees
106
Headquarters
Bridgewater, New Jersey
Founded
—

VYNE Key Statistics

Market Cap
192.67M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
858.47K
High Today
$3.85
Low Today
$3.60
Open Price
$3.84
Volume
1.02M
52 Week High
$13.20
52 Week Low
$3.11

VYNE Earnings

-$0.95
-$0.63
-$0.32
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure